COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Multi-antigen T Cell Infusion Against Neuro-oncologic Disease (REMIND)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03652545
Recruitment Status : Recruiting
First Posted : August 29, 2018
Last Update Posted : July 16, 2020
Children's National Research Institute
Information provided by (Responsible Party):
Catherine Bollard, Children's National Research Institute

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : March 2023
Estimated Study Completion Date : May 2024